TERESA WOOTEN: Open Payments
NPI 1841566585 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,250 in 35 payments from 10 companies in 2025. Trend: 2023 $1,668 · 2024 $1,028 · 2025 $1,250
Food & beverage: $1,250
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $464 |
| Otsuka America Pharmaceutical, Inc. | 7 | $198 |
| E.R. Squibb & Sons, L.L.C. | 5 | $187 |
| Neurocrine BioSciences, Inc. | 2 | $152 |
| Axsome Therapeutics, Inc. | 1 | $80 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $63 |
| Alkermes, Inc. | 2 | $42 |
| Luye Pharma (USA) Ltd. | 1 | $24 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
Products named: VRAYLAR, COBENFY, INGREZZA, REXULTI, Auvelity, CAPLYTA, ABILIFY MAINTENA, ARISTADA.
Industry payments across FL — which companies pay providers there.
